Clinical Trials · NCT00002947
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Yale University
- Enrollment
- 35
- Start date
- Oct 1996
- Locations
- 1 site, United States
- Primary endpoint
- Study in Brain and Central Nervous System Tumors